中国药房2026,Vol.37Issue(17):2229-2234,6.DOI:10.6039/j.issn.1001-0408.2026.17.03
监管周期性对药品互联网零售平台的影响路径分析
An analysis of the impact path of regulatory periodicity on online drug sales platforms
摘要
Abstract
OBJECTIVE To study the impact path of regulatory periodicity on online drug sales platforms(hereinafter referred to as"platform")and provide suggestions for policy makers and platform development.METHODS Annual reports of platform enterprises for content analysis from machine learning were collected.The co-occurrence model and the co-occurrence network structure were built and used to analyze the impact of different regulatory periods on platforms.RESULTS&CONCLUSIONS The co-occurrence model shows that there are four types of impact paths that affect internal and external environments of platforms,including"impact mode","impact implementers","business impact",and"management impact".The co-occurrence network structure further reveals that during the strict regulatory period,platforms'responses to regulations are relatively unitary and concentrate on how to comply and reduce uncertainty.In favorable policy periods,however,platforms shift focus to how to use policy opportunities to innovate online drug sales activities,showing a more diversified network structure.It is suggested that top-level design should be strengthened and a"platform autonomy"mechanism should be introduced;real-time policy adjustment and dynamic supervision mechanisms should be established;platforms should be guided to proactively respond to regulations and implement transformation and upgrading;industry linkage should be strengthened to promote a virtuous cycle of"regulatory policies,platform upgrading,and industry upgrading".关键词
监管周期性/监管政策/药品互联网零售平台/文本分析/共现词分析Key words
regulatory periodicity/regulatory policy/online drug sales platform/content analysis/co-occurrence analysis分类
医药卫生引用本文复制引用
常伟..监管周期性对药品互联网零售平台的影响路径分析[J].中国药房,2026,37(17):2229-2234,6.基金项目
浙江省哲学社会科学规划常规课题(No.24NDJC296YBM) (No.24NDJC296YBM)
教育部人文社会科学研究青年基金项目(No.22YJC630003) (No.22YJC630003)